PRIMARY BILIARY CHOLANGITIS
Clinical trials for PRIMARY BILIARY CHOLANGITIS explained in plain language.
Never miss a new study
Get alerted when new PRIMARY BILIARY CHOLANGITIS trials appear
Sign up with your email to follow new studies for PRIMARY BILIARY CHOLANGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aimed at Hard-to-Treat liver disease
Disease control TerminatedThis study tested whether combining two drugs, obeticholic acid and bezafibrate, could improve liver health in people with primary biliary cholangitis (PBC) who did not get enough help from standard treatment. About 75 adults with PBC took part. The goal was to see if the combina…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE2 • Sponsor: Intercept Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 03:31 UTC
-
PBC drug combo safety checked in Long-Term study
Disease control TerminatedThis study looked at the long-term safety of a fixed-dose combination of two drugs, obeticholic acid and bezafibrate, for people with primary biliary cholangitis (PBC), a chronic liver disease. It enrolled 63 adults who had already been taking the combination in earlier studies. …
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE3 • Sponsor: Intercept Pharmaceuticals • Aim: Disease control
Last updated May 14, 2026 12:04 UTC